Time to onset of effect of biologics and small molecules in moderate-to-severe or acute severe ulcerative colitis - a systematic review and network meta-analysis

被引：0
|
作者：
Attauabi, M. [1 ,2 ]
Dahl, E. K. [1 ]
Burisch, J. [2 ,3 ]
Gubatan, J. [4 ]
Nielsen, O. H. [1 ]
Seidelin, J. B. [1 ]
机构：
[1] Copenhagen Univ Hosp, Dept Gastroenterol & Hepatol, Herlev, Denmark
[2] Hvidovre Univ Hosp, Copenhagen Ctr Inflammatory Bowel Dis Children Ad, Hvidovre, Denmark
[3] Copenhagen Univ Hosp, Gastrounit, Med Sect, Hvidovre, Denmark
[4] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P608
引用
收藏
页码：735 / 737
页数：3
相关论文
共 50 条
  • [1] Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
    Attauabi, Mohamed
    Dahl, Emilie Kristine
    Burisch, Johan
    Gubatan, John
    Nielsen, Ole Haagen
    Seidelin, Jakob Benedict
    [J]. ECLINICALMEDICINE, 2023, 57
  • [2] Systematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis
    Trigo-Vicente, Cristina
    Gimeno-Ballester, Vicente
    Garcia-Lopez, Santiago
    Lopez-Del Val, Alejandro
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (06) : 1411 - 1419
  • [3] Systematic review and network meta-analysis of treatment for moderate-to-severe ulcerative colitis
    Cristina Trigo-Vicente
    Vicente Gimeno-Ballester
    Santiago García-López
    Alejandro López-Del Val
    [J]. International Journal of Clinical Pharmacy, 2018, 40 : 1411 - 1419
  • [4] Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
    Lasa, Juan S.
    Olivera, Pablo A.
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (02): : 161 - 170
  • [5] Remission rates of biologics and small molecules in extension studies of moderate to severe Ulcerative Colitis; A systematic review and Network Meta-analysis
    Godfrey, D.
    Parkash, N.
    Segal, J.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1692 - I1692
  • [6] Efficacy and Safety of Biologics and Small Molecules for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis
    Tsai, Ya-Chu
    Hung, Chen-Yiu
    Tsai, Tsen-Fang
    [J]. PHARMACEUTICS, 2023, 15 (05)
  • [7] Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis
    Burr, Nicholas E.
    Gracie, David J.
    Black, Christopher J.
    Ford, Alexander C.
    [J]. GUT, 2022, 71 (10) : 1976 - +
  • [8] Biologics for pediatric moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis
    Huang, I-Hsin
    Yu, Chia-Ling
    Tai, Cheng-Chen
    Tu, Yu-Kang
    Chi, Ching-Chi
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 (09): : 1201 - 1210
  • [9] Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis
    Bonovas, S.
    Lytras, T.
    Nikolopoulos, G.
    Peyrin-Biroulet, L.
    Danese, S.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (04) : 454 - 465
  • [10] Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis
    Na, Soo-Young
    Choi, Chang Hwan
    Song, Eun Mi
    Bang, Ki Bae
    Park, Sang Hyoung
    Kim, Eun Soo
    Park, Jae Jun
    Keum, Bora
    Lee, Chang Kyun
    Lee, Bo-In
    Ryoo, Seung-Bum
    Koh, Seong-Joon
    Choi, Miyoung
    Kim, Joo Sung
    [J]. INTESTINAL RESEARCH, 2022, : 61 - 87
12345